Skip to content

Jim Flatt

Chief Executive Officer at DMC Biotechnologies.

Raised on DMC Biotechnologies filings

$4.8M

of $10M offered across 1 Form D filing

Form D filings
1
Teammates
1
Last filing
Apr 23, 2025

Company

DMC Biotechnologies

Biotech · Boulder, CO

Specialty chemicals made by microbial fermentation

Investors
9
Still open
$5.2M

DMC Biotechnologies filings

  • EquityFiled Apr 23, 2025Form D
    $4.8M/ $10M

Works with